Genmab AS

Genmab AS Debt/Market Cap

The Debt to Market Capitalization Ratio of Genmab AS (GMAB) as of Nov 22, 2026 is 34.37 %. In the previous year, Debt to Market Capitalization Ratio was 0.60 % — a change of 5,652.17% (higher).

Debt/Market Cap

34.37 %

YoY

5,652.17%

Last updated:

Debt to Market Capitalization Ratio of Genmab AS is 2025 34.37 % . Debt to Market Capitalization Ratio of Genmab AS was 2024 0.60 % . It decreases by 5,652.17% higher compared to the previous year.

The Genmab AS Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2018
0.00 USD
Jan 1, 2019
1.18 USD
Jan 1, 2020
0.27 USD
Jan 1, 2021
0.40 USD
Jan 1, 2022
0.48 USD
Jan 1, 2023
0.58 USD
Jan 1, 2024
0.60 USD
Jan 1, 2025
34.37 USD
The Genmab AS Debt/Market Cap history
YEARDebt/Market CapYoY
34.37 %+5,652.17%
0.60 %+2.22%
0.58 %+21.62%
0.48 %+19.35%
0.40 %+47.62%
0.27 %-76.80%
1.18 %—
0.00—
0.00-100.00%
0.40 %+52,113.56%
0.00-50.21%
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Debt to Market Capitalization Ratio of Genmab AS is 34.37 % in 2025.

Debt to Market Capitalization Ratio of Genmab AS changed from 0.60 % to 34.37 %, representing a 5,652.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Genmab AS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Genmab AS

All Key Metrics — Genmab AS